Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Melanoma 22Carcinoma, Non-Small-Cell Lung 10Neoplasm Metastasis 6Lung Neoplasms 6Brain Neoplasms 6Colorectal Neoplasms 5Skin Neoplasms 4Neoplasms 4Triple Negative Breast Neoplasms 3Thyroid Neoplasms 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Breast Neoplasms 3Uveal Melanoma 2Multiple Myeloma 2Lymphoma 2Leukemia, Hairy Cell 2Hematologic Neoplasms 2Glioma 2Endometrial Neoplasms 2Colonic Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Diseases 1Stomach Neoplasms 1Solid Tumors 1Soft Tissue Neoplasms 1Skin Diseases 1Rectal Neoplasms 1

Interventions

temsirolimus 1binimetinib 1Valproic Acid 1Specimen Handling 1Sirolimus 1Immunoglobulin G 1Disulfides 1Cetuximab 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Soft Tissue Neoplasms × binimetinib × 1 year × Clear all
NCT02285439 2025-10-07

Study of MEK162 for Children With Low-Grade Gliomas

Children's Hospital Los Angeles

Phase 1/2 Completed
105 enrolled 17 charts
CNS

Brain Neoplasms, Soft Tissue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡